Of particular interest is the upregulation of Il-23a, as Il-23 has been shown to be a pro-inflammatory factor and target protein for inhibitory therapy in Crohn’s disease, since it has major effects on Th17 cell differentiation [65]. This evidence concerns the gene IL23A and Crohn disease.